| Descriptor English: | Nelfinavir | ||||
| Descriptor Spanish: | 
                                Nelfinavir                                        
                                        
                                                                                                                            
                                            
  | ||||
| Descriptor Portuguese: | Nelfinavir | ||||
| Descriptor French: | Nelfinavir | ||||
| Entry term(s): | 
                                    AG 1343 AG-1343 AG1343 Mesylate, Nelfinavir Monomethane Sulfonate, Nelfinavir Nelfinavir Mesylate Nelfinavir Monomethane Sulfonate Sulfonate, Nelfinavir Monomethane Viracept  | 
                                            ||||
| Tree number(s): | 
                                        D03.633.100.531.520 | 
                                ||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019888 | ||||
| Scope note: | A potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. | 
                                    ||||
| Allowable Qualifiers: | 
                                                                        AA                                                            analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine  | 
                                            ||||
| Pharm Action: | 
                                                                                                    HIV Protease Inhibitors | 
                                    ||||
| Registry Number: | HO3OGH5D7I | ||||
| Previous Indexing: | 
                                                Isoquinolines (1995-1997) Sulfonic Acids (1995-1997)  | 
                                        ||||
| Public MeSH Note: | 98; NELFINAVIR MESYLATE (now NELFINAVIR) was indexed under ISOQUINOLINES 1997; AG 1343 (now NELFINAVIR) was indexed under ISOQUINOLINES & SULFONIC ACIDS 1995-97 | 
                                                ||||
| History Note: | 98; use NELFINAVIR (NM) 1995-97 | 
                                                ||||
| DeCS ID: | 33415 | ||||
| Unique ID: | D019888 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1998/01/01 | ||||
| Date of Entry: | 1997/06/20 | ||||
| Revision Date: | 2017/05/24 | 
- 
                                    
- 
                                        CHEMICALS AND DRUGS
 
Heterocyclic Compounds [D03]Heterocyclic Compounds 
| 
                                                             | 
                                
                        
                                                                    
                        Nelfinavir                                            
                                        - Preferred                                        
                                                                
                                
                        
                        
                        
                                                                    
                        Viracept                                            
                                        - Narrower                                        
                                                                
                                
                                                                    
                        AG 1343                                            
                                        - Narrower                                        
                                                                
                                
                                                                    
                        Nelfinavir Mesylate                                            
                                        - Narrower                                        
                                                                
                                
                        
                        
                    
                    
                
                | Concept UI | 
                                        
                                        M0029531 | 
                                
| Scope note | A potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. | 
| Preferred term | Nelfinavir | 
| Concept UI | 
                                        
                                        M0029530 | 
                                
| Preferred term | Viracept | 
| Concept UI | 
                                        
                                        M0353763 | 
                                
| Preferred term | AG 1343 | 
| Entry term(s) | 
                                        
                                                                                            AG-1343                                                 AG1343  | 
                                
| Concept UI | 
                                        
                                        M0329047 | 
                                
| Preferred term | Nelfinavir Mesylate | 
| Entry term(s) | 
                                        
                                                                                            Mesylate, Nelfinavir                                                 Monomethane Sulfonate, Nelfinavir Nelfinavir Monomethane Sulfonate Sulfonate, Nelfinavir Monomethane  | 
                                
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey